• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲癣。一项观察性研究的基线结果。

Onychomycosis. Baseline results of an observational study.

作者信息

Schein J R, Gause D, Stier D M, Lubeck D P, Bates M M, Fisk R

机构信息

Novartis Pharmaceuticals Corp, East Hanover, NJ 07936, USA.

出版信息

J Am Podiatr Med Assoc. 1997 Nov;87(11):512-9. doi: 10.7547/87507315-87-11-512.

DOI:10.7547/87507315-87-11-512
PMID:9397656
Abstract

The investigators present an analysis of baseline quality-of-life and patient-management approaches from an observational study of 150 patients being treated by podiatric physicians and dermatologists for onychomycosis. The majority (73%) made the initial office visit specifically because of their onychomycosis. Both men and women indicated that they had substantial physical discomfort as well as concerns related to appearance. Women reported significantly more problems than did men as a result of their onychomycosis. Physicians reported that 54% of patients suffered from toenail discomfort, 36% had pain while walking, 40% reported that their condition limited wearing of shoes, and 67% were embarrassed by the condition. The results of this study suggest that the treatment approach of podiatric physicians is more likely to address the palliative concerns of patients with onychomycosis, while the approach of dermatologists is more likely to attempt a definitive cure.

摘要

研究人员对150名接受足病医生和皮肤科医生治疗甲癣的患者进行了一项观察性研究,分析了其基线生活质量和患者管理方法。大多数患者(73%)首次到诊所就诊明确是因为甲癣。男性和女性均表示他们有明显的身体不适以及对外表的担忧。女性因甲癣报告的问题明显多于男性。医生报告称,54%的患者有脚趾甲不适,36%的患者走路时疼痛,40%的患者表示病情限制了鞋子的穿着,67%的患者因病情而感到尴尬。这项研究的结果表明,足病医生的治疗方法更有可能解决甲癣患者的姑息治疗问题,而皮肤科医生的方法更有可能尝试彻底治愈。

相似文献

1
Onychomycosis. Baseline results of an observational study.甲癣。一项观察性研究的基线结果。
J Am Podiatr Med Assoc. 1997 Nov;87(11):512-9. doi: 10.7547/87507315-87-11-512.
2
[How to improve efficacy of onychomycosis treatment?].[如何提高甲癣治疗的疗效?]
Wiad Parazytol. 2001;47(4):823-32.
3
Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis-specific questionnaire.使用国际特定甲真菌病问卷的波兰语版本评估趾甲甲真菌病患者的生活质量。
J Eur Acad Dermatol Venereol. 2007 Apr;21(4):491-6. doi: 10.1111/j.1468-3083.2006.02004.x.
4
Onychomycosis: diagnosis and systemic treatment.甲癣:诊断与全身治疗
Nurse Pract. 1998 Dec;23(12):40-2, 45-8, 51.
5
[Epidemiology and management of onychomycosis in private dermatological practice in France].[法国私立皮肤科诊所中甲癣的流行病学与管理]
Ann Dermatol Venereol. 2008 Aug-Sep;135(8-9):561-6. doi: 10.1016/j.annder.2008.05.004. Epub 2008 Aug 8.
6
Prognostic factors for cure following treatment of onychomycosis.治疗甲真菌病后治愈的预后因素。
J Eur Acad Dermatol Venereol. 2010 Jun;24(6):679-84. doi: 10.1111/j.1468-3083.2009.03487.x. Epub 2009 Nov 19.
7
Onychomycosis Diagnosis and Management: Perspectives from a Joint Dermatology-Podiatry Roundtable.甲癣的诊断与管理:皮肤科-足病科联合圆桌会议观点
J Drugs Dermatol. 2015 Sep;14(9):1016-21.
8
Patient satisfaction with oral versus nonoral therapeutic approaches in onychomycosis.甲癣患者对口服与非口服治疗方法的满意度。
J Am Podiatr Med Assoc. 2001 Nov-Dec;91(10):521-7. doi: 10.7547/87507315-91-10-521.
9
Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.口服特比萘芬治疗甲癣的安全性和有效性:在开放性随机试验“改善甲癣治疗结果——特比萘芬与清创术联用(IRON-CLAD)”中老年亚组分析
Am J Geriatr Pharmacother. 2006 Mar;4(1):1-13. doi: 10.1016/j.amjopharm.2005.12.012.
10
Diagnosis and Management of Onychomycosis Perspectives from a Joint Podiatric Medicine-Dermatology Roundtable.足病医学与皮肤病学联合圆桌会议视角下的甲癣诊断与管理
J Am Podiatr Med Assoc. 2016 Mar;106(2):155-62. doi: 10.7547/14-170.

引用本文的文献

1
Extended Use of Topical Efinaconazole Remains Safe and Can Provide Continuing Benefits for Dermatophyte Toenail Onychomycosis.外用艾氟康唑的长期使用仍然安全,并且可为皮肤癣菌性 toenail 甲真菌病提供持续益处。 (注:这里“toenail”直译为“脚趾甲”,结合语境可能是想表达“趾甲”,整体译文稍显奇怪,推测原文可能存在部分错误表述,但按要求准确翻译如上。)
J Fungi (Basel). 2024 Aug 30;10(9):620. doi: 10.3390/jof10090620.
2
On the Basis of Sex: Impact and Treatment of Toenail Onychomycosis in Female Patients.基于性别:女性患者趾甲甲真菌病的影响与治疗
J Clin Aesthet Dermatol. 2023 Oct;16(10):52-57.
3
More than Nail Deep: The Effect of Efinaconazole 10% Treatment on the Quality of Life in Patients with Onychomycosis: A post hoc Study.
不止于指甲深层:10%艾氟康唑治疗甲真菌病患者生活质量的影响:一项事后分析研究
Skin Appendage Disord. 2021 Jun;7(4):272-279. doi: 10.1159/000514361. Epub 2021 May 19.
4
Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm study.长期使用 10%依氟康唑溶液治疗甲真菌病患者(包括重症病例)的疗效:一项多中心、单臂研究。
J Dermatol. 2019 Aug;46(8):641-651. doi: 10.1111/1346-8138.14935. Epub 2019 Jun 17.
5
Patient-Reported Outcomes in Onychomycosis: A Review of Psychometrically Evaluated Instruments in Assessing Treatment Effectiveness.甲癣患者报告的结局:评估治疗效果的心理测量学评估工具综述
Skin Appendage Disord. 2017 Aug;3(3):144-155. doi: 10.1159/000469666. Epub 2017 Apr 21.
6
Onychomycosis: Practical Approaches to Minimize Relapse and Recurrence.甲癣:减少复发的实用方法
Skin Appendage Disord. 2016 Sep;2(1-2):83-87. doi: 10.1159/000448056. Epub 2016 Sep 14.
7
Onychomycosis of Toenails and Post-hoc Analyses with Efinaconazole 10% Solution Once-daily Treatment: Impact of Disease Severity and Other Concomitant Associated Factors on Selection of Therapy and Therapeutic Outcomes.toenails的甲真菌病以及使用10%艾氟康唑溶液每日一次治疗的事后分析:疾病严重程度和其他伴随相关因素对治疗选择和治疗结果的影响。
J Clin Aesthet Dermatol. 2016 Feb;9(2):42-7.
8
Risk Factors and Comorbidities for Onychomycosis: Implications for Treatment with Topical Therapy.甲癣的危险因素和合并症:对局部治疗的启示
J Clin Aesthet Dermatol. 2015 Nov;8(11):38-42.
9
Patient considerations in the management of toe onychomycosis - role of efinaconazole.趾甲真菌病治疗中的患者考量——艾氟康唑的作用
Patient Prefer Adherence. 2015 Jun 30;9:887-91. doi: 10.2147/PPA.S72701. eCollection 2015.
10
Efinaconazole in the treatment of onychomycosis.艾氟康唑治疗甲癣
Infect Drug Resist. 2015 Jun 1;8:163-72. doi: 10.2147/IDR.S69596. eCollection 2015.